PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

N anox.AI uses AI to help identify asymptomatic undetected chronic conditions early by analyzing routine medical CT scans.

University College Dublin (UCD) researcher Dr Nicola Fletcher has received a coveted European Research Council (ERC) Synergy ...

University College Dublin (UCD) researcher Dr. Nicola Fletcher has received a coveted European Research Council (ERC) Synergy ...

(see more details here). A patient in an imaging room, their medical diagnosis in the hands of Nanox's tomographic imaging. NANO-X IMAGING LTD (NASDAQ:NNOX) is a healthcare company based in Israel.

Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository ...

Dr. Wimpfheimer is the Chief Medical Officer at Nanox and previously held the position of Chief Medical Officer and Head of Product Strategy at Zebra Medical Vision, until its acquisition by Nanox.

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ...

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ...

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X ...